Taro Pharmaceutical Industries Ltd (NYSE:TARO)

114.55
Delayed Data
As of 11:17am ET
 +2.11 / +1.87%
Today’s Change
93.01
Today|||52-Week Range
128.46
+9.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line360.9M484.8M541.3M456.7M
 
 
 
 
 
Depreciation16.6M15.8M14.8M14.8M
 
 
 
 
 
Total Other Cash Flow-7.6M-12.7M-11.9M-27.6M
 
 
 
 
 
Funds From Operations346.1M417.5M532.3M517.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-11.6M10.7M137.2M80.1M
 
 
 
 
 
Net Cash Flow - Operating Activities357.6M406.8M395.1M437.5M
 
 
 
 
 
 
InvestingIncrease In Investments-120.7M-43.3M-220.2M--
 
 
 
 
Decrease In Investments7.2M111.0K--196.1M
 
 
 
 
Capital Expenditures-21.2M-20.0M-19.0M-35.8M
 
 
 
 
 
Fixed Asset Disposal8.0K217.0K0.008.5M
 
 
 
 
Other Investing - Uses-34.0M-31.1M-80.6M-286.6M
 
 
 
 
 
Other Investing - Sources0.002.1M35.0M10.0K
 
 
 
 
Net Cash Flow Investing-173.3M-92.1M-284.9M-117.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-11.9M-10.9M-5.9M0.00
 
 
 
 
Net Proceeds Stock Sale1.3M26.0K0.000.00
 
 
 
Common Preferred Redeemed-193.0M0.00-9.5M-294.9M
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing149.0K0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-203.5M-10.9M-15.3M-294.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-8.2M-32.1M57.0K-1.2M
 
 
 
 
 
 
Net Change In Cash-19.1M303.8M94.9M24.9M